UnitedHealth Group Inc (UNH) Holdings Cut by Orrstown Financial Services Inc.

Orrstown Financial Services Inc. reduced its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 10.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,174 shares of the healthcare conglomerate’s stock after selling 691 shares during the quarter. UnitedHealth Group accounts for approximately 1.6% of Orrstown Financial Services Inc.’s investment portfolio, making the stock its 10th biggest holding. Orrstown Financial Services Inc.’s holdings in UnitedHealth Group were worth $1,361,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Beach Investment Management LLC. acquired a new position in shares of UnitedHealth Group in the second quarter valued at $556,000. Adell Harriman & Carpenter Inc. increased its holdings in shares of UnitedHealth Group by 12.0% in the second quarter. Adell Harriman & Carpenter Inc. now owns 14,661 shares of the healthcare conglomerate’s stock valued at $2,718,000 after purchasing an additional 1,565 shares during the last quarter. Marshall Wace North America L.P. increased its holdings in shares of UnitedHealth Group by 56.5% in the second quarter. Marshall Wace North America L.P. now owns 511,514 shares of the healthcare conglomerate’s stock valued at $94,630,000 after purchasing an additional 184,719 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after purchasing an additional 11,361 shares during the last quarter. Finally, Cadence Capital Management LLC increased its holdings in shares of UnitedHealth Group by 42.4% in the second quarter. Cadence Capital Management LLC now owns 8,477 shares of the healthcare conglomerate’s stock valued at $1,572,000 after purchasing an additional 2,523 shares during the last quarter. 85.65% of the stock is currently owned by hedge funds and other institutional investors.

Several equities analysts have commented on the stock. Deutsche Bank upped their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Jefferies Group reiterated a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a report on Friday, December 1st. Finally, Evercore ISI reiterated an “outperform” rating and issued a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $243.22.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $229.37 on Tuesday. The stock has a market cap of $222,270.00, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group Inc has a one year low of $156.49 and a one year high of $250.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the company posted $2.11 earnings per share. equities analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. UnitedHealth Group’s payout ratio is 31.58%.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now directly owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Michele J. Hooper sold 10,000 shares of the stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the sale, the director now owns 37,284 shares in the company, valued at $8,864,643.84. The disclosure for this sale can be found here. Insiders have sold 53,396 shares of company stock worth $12,262,067 over the last quarter. Corporate insiders own 0.89% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://ledgergazette.com/2018/02/20/unitedhealth-group-inc-unh-holdings-cut-by-orrstown-financial-services-inc.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply